A comprehensive view of Fertility/Reproductive Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Consumer Council study of anti-stretch mark products for pregnant, postnatal women finds certain models have potentially harmful synthetic musks/phthalates, may risk foetal and infant exposure; group urges mothers to avoid exposure by checking ingredients

TikTok videos blame TiO2 in tampon strings for host of medical problems, but doctor says there's no evidence TiO2 in tampons causes reproductive harm; professional group also says there's no evidence suggesting any tampons are safer than any other tampons

Social media users call for boycott of Walgreens after customers documented issues filling prescriptions for birth control, buying condoms; competitor CVS has similar policy to deny prescriptions that conflict with their religious or moral beliefs

Global in-vitro fertilization services market expected to reach US$1.2B by 2028, with 8.9% CAGR growth from 2022-2028; growth driven by new technologies, lower conception rates, shifting lifestyles, reproductive diseases

Perrigo's HRA Pharma submits application to FDA to switch Opill daily birth control pill from prescription-only to OTC; if approved, Opill would be first OTC birth control pill in US, where every year 6.1 million pregnancies are unintentional

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count